ETR/ABL (ETR/ABL)

Deutsche Börse Xetra: ETR/ABL · EUR

€92.6

-0.12 (-0.1%)· Recorded snapshot

Market cap	159.9B
Revenue (ttm)	42.5B
Net income (ttm)	4.1B
EPS (ttm)	€2.42
P/E (trailing)	38.3x
P/E (forward)	17.5x
Dividend	€2.19 (2.37%)
Volume	115
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 42.5B
Net income (ttm): 4.1B
EPS (ttm): €2.42
P/E (trailing): 38.3x
P/E (forward): 17.5x
Market cap: 159.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E17.5

P25 n/aP50 n/aP75 n/a

Trailing P/E38.3

P25 n/aP50 n/aP75 n/a

ROE10.6

P25 n/aP50 n/aP75 n/a

ROIC7.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ETR/ABL indicators

Market & fundamental data

Available fields

239

Groups with data

Currency

USD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-10-21
Employees	122,000
Employees change	7,000
Employees growth	6.09%
Enterprise value	EUR 184.8B
Exchange	Deutsche Börse Xetra
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1888
Industry	Medical Devices
Is primary listing	No
ISIN number	US0028241000
Last earnings date	2026-10-21
Last refreshed	2026-10-28
Market cap	EUR 159.9B
Price	EUR 92.56
Price currency	EUR
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	etr/ABL
Website	https://www.abbott.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	50.21x
Average P/E ratio (3Y)	27.41x
Average P/E ratio (5Y)	28.1x
Earnings yield	2.61%
EV/Earnings	44.93x
EV/EBIT	25.83x
EV/EBITDA	16.7x
EV/FCF	26.31x
EV/Sales	4.27x
FCF / EV yield	3.8%
FCF yield	4.39%
Forward P/E	17.55x
Graham number	37.3432
Graham upside	-59.41%
Industry forward P/E	17.57x
Industry P/E	20.35x
Lynch fair value	EUR 11.83
Lynch upside	-87.14%
P/(FCF - SBC) ratio	25.06x
P/(OCF - SBC) ratio	19.39x
P/B ratio	3.51x
P/E ratio	38.27x
P/FCF ratio	22.76x
P/OCF ratio	17.98x
P/S ratio	3.77x
Price/EBITDA ratio	15.21x
Sector forward P/E	14.95x
Sector P/E	40.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.55%
EBITDA margin	24.79%
Effective tax rate	28.36%
FCF margin	16.8%
Gross margin	57.08%
Operating margin	16.55%
Pretax margin	13.61%
Profit margin	9.75%
Profit per employee	EUR 35,814
Profitable quarters	35
Profitable years	41
Revenue per employee	EUR 369,308
ROA	5.33%
ROA (5Y)	6.84%
ROCE	9.01%
ROE	10.58%
ROE (5Y)	19.7%
ROIC	7.25%
ROIC (5Y)	14.92%
SBC / revenue	1.54%
Tax / revenue	3.86%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-66.24%
EPS growth (Q)	-43.69%
EPS growth (QoQ)	-0.12%
EPS growth 10Y	11.38%
EPS growth 3Y	-2.87%
EPS growth 5Y	-7.76%
EPS growth years	0
FCF growth	15.48%
FCF growth 3Y	12.55%
FCF growth 5Y	-1.97%
Gross profit growth	12.07%
Gross profit growth (Q)	17.95%
Gross profit growth 3Y	7.75%
Gross profit growth 5Y	2.62%
Net income growth	-66.37%
Net income growth (Q)	-44.04%
Net income growth (QoQ)	-0.86%
Net income growth 3Y	-3.11%
Net income growth 5Y	-8.3%
Net income growth years	0
OCF growth	9.61%
OCF growth 10Y	13.31%
OCF growth 3Y	9.95%
OCF growth 5Y	-1.4%
Operating income growth	-5.19%
Operating income growth (Q)	-33.06%
Operating income growth 3Y	5.37%
Operating income growth 5Y	-2.23%
Revenue growth	10%
Revenue growth (Q)	14.46%
Revenue growth (QoQ)	3.34%
Revenue growth 10Y	8.82%
Revenue growth 3Y	6.47%
Revenue growth 5Y	2.65%
Revenue growth quarters	12
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -1.9B
Depreciation and amortization	EUR 3.6B
EBIT	EUR 7B
EBITDA	EUR 10.5B
EPS	EUR 2.42
Financing cash flow	EUR 9.6B
Free cash flow	EUR 7B
Free cash flow minus SBC	EUR 6.4B
Gross profit	EUR 24.2B
Income taxes	EUR 1.6B
Investing cash flow	EUR -20.1B
Net borrowing	EUR 14.9B
Net cash flow	EUR -1.7B
Net income	EUR 4.1B
Operating cash flow minus SBC	EUR 8.3B
Operating income	EUR 7B
Revenue	EUR 42.5B
Stock-based compensation	EUR 645.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 26.01
Debt / EBITDA	2.65
Debt / equity	0.63
Debt / FCF	4.1
Interest coverage	7.87
Net cash (debt)	EUR -23.9B
Net cash / market cap	-14.91%
Net debt / EBITDA	2.27
Net debt / equity	0.52
Net debt / FCF	3.39
Piotroski F-Score	5
Shareholders' equity	EUR 45.6B
Tangible book value	EUR -1.2B
Tangible book value per share	EUR -0.68
Total cash	EUR 4.9B
Total debt	EUR 28.8B
WACC	6.66%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.48
Current ratio	1.38
Inventory turnover	2.82
Quick ratio	0.8
Working capital	EUR 6B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.25%
Dividend growth	4.03%
Dividend growth (10Y)	8.86%
Dividend growth (3Y)	5.28%
Dividend growth (5Y)	7.63%
Dividend growth years	7
Dividend payment date	2026-11-16
Dividend payment years	33
Dividend payout frequency	Quarterly
Dividend per share	EUR 2.19
Dividend yield	2.37%
Ex-dividend date	2026-10-15
Last dividend	EUR 0.57
Payout ratio	90.9%
Shareholder yield	2.63%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	153.76%
10Y return CAGR	11.84%
10Y total return	206.21%
150-day SMA	EUR 85.58
1D price change	-0.13%
1M price change	3.88%
1M total return	4.52%
1W price change	0.78%
1W total return	0.78%
1Y price change	-14.58%
1Y return CAGR	-12.47%
1Y total return	-12.46%
20-day SMA	EUR 90.39
200-day SMA	EUR 87.83
3M price change	-0.32%
3M total return	0.29%
3Y price change	5.3%
3Y return CAGR	3.9%
3Y total return	12.16%
50-day SMA	EUR 91.61
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 113.36
52-week high date	2025-11-17
52-week low	EUR 70.10
52-week low date	2026-05-11
5Y price change	-15.78%
5Y return CAGR	-1.44%
5Y total return	-6.98%
6M price change	16.57%
6M total return	18.12%
All-time high	EUR 134.14
All-time high date	2025-03-04
All-time low	EUR 24.00
All-time low date	2013-10-01
Average true range (ATR)	EUR 1.99
Average volume	685.4
Beta (5Y)	0.58
Change from 52-week high	-18.35%
Change from 52-week low	32.04%
Change from all-time high	-31%
Change from all-time low	285.67%
Change from open	0.63%
Day's gap	-0.76%
Dollar volume	EUR 10,644
High price	EUR 92.72
Low price	EUR 91.88
Monthly RSI	46.74
Open price	EUR 91.98
Position in 52-week range	80.95%
Previous close	EUR 92.68
Price vs 150-day SMA	8.16%
Price vs 20-day SMA	2.4%
Price vs 200-day SMA	5.39%
Price vs 50-day SMA	1.03%
Relative volume	0.17
RSI	54.84
Sharpe ratio	-0.47
Sharpe ratio (3Y)	0.07
Sharpe ratio (5Y)	-0.16
Sortino ratio	-0.45
Sortino ratio (3Y)	0.35
Sortino ratio (5Y)	0.02
Volume	115
Weekly RSI	53.38
YTD price change	-12.61%
YTD total return	-10.45%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.7B
Shares change (QoQ)	-0.29%
Shares change (YoY)	-0.25%
Shares held by insiders	0.5%
Shares held by institutions	80.98%
Short ratio	1.9 days

Deeper analysis on ETR/ABL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ETR/ABL report

Is a complete ETR/ABL research report available?

No complete published report is available for etr/ABL (ETR/ABL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ETR/ABL (ETR/ABL)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/ABL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/ABL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ETR/ABL

Frequently asked questions